Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Treatment of AMI

AMI patients administered aspirin within 24 hours of admission

Measure Source

CMS Health Care Quality Improvement Program (HCQIP) Quality Indicator.

Tables

Data source does not support detailed tables.

Data Source

Centers for Medicare and Medicaid Services, Medicare Quality Improvement Organization Program.

Denominator

Medicare discharges age 18 and over with a principal diagnosis of AMI (ICD-9 codes 410.00, 410.01, 410.10, 410.11, 410.20, 410.21, 410.30, 410.31, 410.40, 410.41, 410.50 410.51, 410.60, 410.61, 410.70, 410.71, 410.80, 410.81, 410.90, 410.91).

Excludes patients transferred to another acute care hospital on day of arrival, patients received in transfer from another hospital, including another emergency department, patients discharged on day of arrival, patients who expired on day of arrival.

Excludes patients with one or more of the following aspirin contraindications documented in the medical record: bleeding on admission, aspirin allergy, history of internal bleeding or bleeding/coagulation disorder, chronic liver disease, platelet count < 100 x 109/L on admission, anemia, treatment with warfarin prior to admission, history of peptic ulcer disease, admission serum creatinine >3 mg/dL.

Numerator

Subset of AMI denominator patients who received aspirin within 24 hours before or after hospital arrival.

Comments

This measure is also a JCAHO core measure.

 

AHRQ Advancing Excellence in Health Care